These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 7496972)
21. Enterovirus infection can induce immune responses that cross-react with beta-cell autoantigen tyrosine phosphatase IA-2/IAR. Härkönen T; Lankinen H; Davydova B; Hovi T; Roivainen M J Med Virol; 2002 Mar; 66(3):340-50. PubMed ID: 11793386 [TBL] [Abstract][Full Text] [Related]
22. Antigenic structure of the hepatitis C virus envelope 2 protein. Zhang ZX; Sönnerborg A; Sällberg M Clin Exp Immunol; 1994 Dec; 98(3):382-7. PubMed ID: 7527739 [TBL] [Abstract][Full Text] [Related]
23. Different Antibody Response against the Coxsackievirus A16 VP1 Capsid Protein: Specific or Non-Specific. Ding Y; Wang Z; Zhang X; Teng Z; Gao C; Qian B; Wang L; Feng J; Wang J; Zhao C; Guo C; Pan W PLoS One; 2016; 11(9):e0162820. PubMed ID: 27622652 [TBL] [Abstract][Full Text] [Related]
24. Establishment of a panel of in-house polyclonal antibodies for the diagnosis of enterovirus infections. Kotani O; Iwata-Yoshikawa N; Suzuki T; Sato Y; Nakajima N; Koike S; Iwasaki T; Sata T; Yamashita T; Minagawa H; Taguchi F; Hasegawa H; Shimizu H; Nagata N Neuropathology; 2015 Apr; 35(2):107-21. PubMed ID: 25263613 [TBL] [Abstract][Full Text] [Related]
25. Coxsackievirus B1-based antibody-capture enzyme-linked immunosorbent assay for detection of immunoglobulin G (IgG), IgM, and IgA with broad specificity for enteroviruses. Swanink CM; Veenstra L; Poort YA; Kaan JA; Galama JM J Clin Microbiol; 1993 Dec; 31(12):3240-6. PubMed ID: 8308117 [TBL] [Abstract][Full Text] [Related]
26. A point mutation in VP1 of coxsackievirus B4 alters antigenicity. Halim S; Ramsingh AI Virology; 2000 Mar; 269(1):86-94. PubMed ID: 10725201 [TBL] [Abstract][Full Text] [Related]
27. Mapping of antigenic domains in poliovirus VP1 involved in structural rearrangements during virus morphogenesis and antigenic alterations of the virion. Ketterlinus R; Wiegers K Virology; 1994 Oct; 204(1):27-37. PubMed ID: 7522372 [TBL] [Abstract][Full Text] [Related]
28. Ability of linear and cyclic peptides of neutralization antigenic site 1 of poliovirus type 1 to induce virus cross-reactive and neutralizing antibodies. van der Werf S; Briand JP; Plaué S; Burckard J; Girard M; Van Regenmortel MH Res Virol; 1994; 145(6):349-59. PubMed ID: 7535942 [TBL] [Abstract][Full Text] [Related]
29. Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak. Shaw J; Jorba J; Zhao K; Iber J; Chen Q; Adu F; Adeniji A; Bukbuk D; Baba M; Henderson E; Dybdahl-Sissoko N; McDonald S; Weldon WC; Gumede N; Oberste MS; Kew OM; Burns CC J Virol; 2018 May; 92(9):. PubMed ID: 29444940 [TBL] [Abstract][Full Text] [Related]
30. Type-specific and cross-reactive antigenicity of capsid proteins VP1 and VP2 of echovirus type 7. Hasegawa A; Inouye S Microbiol Immunol; 1983; 27(10):869-76. PubMed ID: 6199652 [TBL] [Abstract][Full Text] [Related]
31. Serological detection and analysis of anti-VP1 responses against various enteroviruses (EV) (EV-A, EV-B and EV-C) in Chinese individuals. Gao C; Ding Y; Zhou P; Feng J; Qian B; Lin Z; Wang L; Wang J; Zhao C; Li X; Cao M; Peng H; Rui B; Pan W Sci Rep; 2016 Feb; 6():21979. PubMed ID: 26917423 [TBL] [Abstract][Full Text] [Related]
32. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site. Blondel B; Crainic R; Fichot O; Dufraisse G; Candrea A; Diamond D; Girard M; Horaud F J Virol; 1986 Jan; 57(1):81-90. PubMed ID: 2416957 [TBL] [Abstract][Full Text] [Related]
33. Antigenic sites of coxsackievirus A9. Pulli T; Lankinen H; Roivainen M; Hyypiä T Virology; 1998 Jan; 240(2):202-12. PubMed ID: 9454693 [TBL] [Abstract][Full Text] [Related]
34. Intertypic common antigens of seven types of human enteroviruses. Ku FZ; Liu Y Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(2):91-8. PubMed ID: 2829160 [No Abstract] [Full Text] [Related]
35. Characterization of the N-terminal part of the neutralizing antigenic site I of coxsackievirus B4 by mutation analysis of antigen chimeras. McPhee F; Zell R; Reimann BY; Hofschneider PH; Kandolf R Virus Res; 1994 Nov; 34(2):139-51. PubMed ID: 7531922 [TBL] [Abstract][Full Text] [Related]
36. Spectrum of monoclonal antibodies to coxsackievirus B-3 includes type- and group-specific antibodies. Yagi S; Schnurr D; Lin J J Clin Microbiol; 1992 Sep; 30(9):2498-501. PubMed ID: 1328290 [TBL] [Abstract][Full Text] [Related]
37. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides. Haarmann CM; Schwimmbeck PL; Mertens T; Schultheiss HP; Strauer BE Virology; 1994 May; 200(2):381-9. PubMed ID: 7513917 [TBL] [Abstract][Full Text] [Related]
39. The role of conserved arginine and proline residues in enterovirus VP1 protein. Huang YL; Lin TM; Wang SY; Wang JR J Microbiol Immunol Infect; 2022 Aug; 55(4):590-597. PubMed ID: 35232679 [TBL] [Abstract][Full Text] [Related]
40. Cross reactivity among human enterovirus serotypes as revealed by microneutralization assay technique. Danes L; Sladká E; Hancil J; Horácek J J Hyg Epidemiol Microbiol Immunol; 1988; 32(2):233-8. PubMed ID: 2842392 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]